Unknown

Dataset Information

0

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report.


ABSTRACT: Background:Uterine serous carcinoma (USC) is a biologically aggressive variant of uterine cancer. Effective treatment options for recurrent, chemotherapy-resistant USC are extremely limited. Case:We describe a 74-year-old woman with recurrent and widespread treatment-resistant disease, who experienced a dramatic response to sacituzumab govitecan, a novel antibody-drug conjugate (ADC) targeting human trophoblast-cell-surface antigen (TROP-2), after failing multiple chemotherapy and immunotherapy. The impressive clinical response (66% reduction of target lesions by RECIST 1.1 with a duration response of over 10?months) was confirmed with serial CT scans in the absence of significant adverse events. Conclusion:Sacituzumab govitecan may present a new treatment option for recurrent USC patients harboring Trop-2+ tumors resistant to chemotherapy. Clinical trials with sacituzumab govitecan are warranted.

SUBMITTER: Han C 

PROVIDER: S-EPMC6030029 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report.

Han Chanhee C   Bellone Stefania S   Schwartz Peter E PE   Govindan Serengulam V SV   Sharkey Robert M RM   Goldenberg David M DM   Santin Alessandro D AD  

Gynecologic oncology reports 20180523


<h4>Background</h4>Uterine serous carcinoma (USC) is a biologically aggressive variant of uterine cancer. Effective treatment options for recurrent, chemotherapy-resistant USC are extremely limited.<h4>Case</h4>We describe a 74-year-old woman with recurrent and widespread treatment-resistant disease, who experienced a dramatic response to sacituzumab govitecan, a novel antibody-drug conjugate (ADC) targeting human trophoblast-cell-surface antigen (TROP-2), after failing multiple chemotherapy and  ...[more]

Similar Datasets

| S-EPMC7007291 | biostudies-literature
| S-EPMC4673178 | biostudies-literature
| S-EPMC7075468 | biostudies-literature
| S-EPMC5559902 | biostudies-literature
| S-EPMC7288263 | biostudies-literature
| S-EPMC9263779 | biostudies-literature
| S-EPMC10265462 | biostudies-literature
| S-EPMC10468580 | biostudies-literature
| S-EPMC10113938 | biostudies-literature
| S-EPMC9073796 | biostudies-literature